Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Agenus Return on Tangible Equity 2010-2025 | AGEN

Current and historical return on tangible equity values for Agenus (AGEN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Agenus Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $-0.17B $-0.36B 48.96%
2025-03-31 $-0.19B $-0.35B 61.59%
2024-12-31 $-0.23B $-0.33B 82.32%
2024-09-30 $-0.23B $-0.30B 95.88%
2024-06-30 $-0.22B $-0.25B 112.77%
2024-03-31 $-0.24B $-0.22B 147.76%
2023-12-31 $-0.25B $-0.18B 191.41%
2023-09-30 $-0.27B $-0.14B 256.53%
2023-06-30 $-0.26B $-0.11B 327.50%
2023-03-31 $-0.24B $-0.08B 410.30%
2022-12-31 $-0.22B $-0.09B 568.83%
2022-09-30 $-0.21B $-0.04B 1646.15%
2022-06-30 $0.02B $-0.02B -1028.57%
2022-03-31 $-0.02B $-0.01B 27.34%
2021-12-31 $-0.03B $0.02B 19.80%
2021-09-30 $0.00B $0.00B -1.56%
2021-06-30 $-0.23B $-0.29B 89.33%
2021-03-31 $-0.19B $-0.23B 77.64%
2020-12-31 $-0.18B $-0.25B 73.68%
2020-09-30 $-0.17B $-0.24B 69.25%
2020-06-30 $-0.17B $-0.26B 67.53%
2020-03-31 $-0.17B $-0.24B 73.58%
2019-12-31 $-0.11B $-0.27B 51.11%
2019-09-30 $-0.13B $-0.24B 63.66%
2019-06-30 $-0.11B $-0.20B 62.72%
2019-03-31 $-0.09B $-0.15B 51.76%
2018-12-31 $-0.16B $-0.21B 94.53%
2018-09-30 $-0.15B $-0.17B 101.38%
2018-06-30 $-0.15B $-0.15B 120.08%
2018-03-31 $-0.16B $-0.15B 154.15%
2017-12-31 $-0.12B $-0.11B 167.47%
2017-09-30 $-0.11B $-0.09B 176.38%
2017-06-30 $-0.12B $-0.06B 206.22%
2017-03-31 $-0.11B $-0.03B 232.12%
2016-12-31 $-0.13B $-0.08B 317.50%
2016-09-30 $-0.12B $-0.06B 883.02%
2016-06-30 $-0.09B $-0.02B -593.33%
2016-03-31 $-0.10B $0.00B -276.71%
2015-12-31 $-0.09B $0.03B -214.63%
2015-09-30 $-0.10B $0.05B -294.74%
2015-06-30 $-0.09B $0.06B -357.69%
2015-03-31 $-0.06B $0.02B -338.89%
2014-12-31 $-0.04B $0.00B -193.10%
2014-09-30 $-0.02B $0.02B -107.32%
2014-06-30 $-0.02B $0.03B -155.56%
2014-03-31 $-0.02B $0.04B -2400.00%
2013-12-31 $-0.03B $-0.01B 231.58%
2013-09-30 $-0.03B $-0.01B 188.57%
2013-06-30 $-0.03B $-0.02B 158.02%
2013-03-31 $-0.03B $-0.03B 149.33%
2012-12-31 $-0.01B $-0.02B 76.19%
2012-09-30 $-0.01B $-0.02B 72.73%
2012-06-30 $-0.01B $-0.01B 69.57%
2012-03-31 $-0.01B $-0.01B 58.67%
2011-12-31 $-0.02B $-0.02B 124.68%
2011-09-30 $-0.02B $-0.02B 118.31%
2011-06-30 $-0.02B $-0.02B 105.00%
2011-03-31 $-0.02B $-0.02B 96.39%
2010-12-31 $-0.02B $-0.02B 96.84%
2010-09-30 $-0.02B $-0.03B 72.73%
2010-06-30 $-0.02B $-0.02B 97.87%
2010-03-31 $-0.03B $-0.03B 115.38%
2009-12-31 $-0.03B $-0.02B 110.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.133B $0.103B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $247.799B 18.08
Amgen (AMGN) United States $154.892B 13.19
Gilead Sciences (GILD) United States $140.174B 14.60
Vertex Pharmaceuticals (VRTX) United States $100.254B 25.84
Bristol Myers Squibb (BMY) United States $96.032B 7.01
GSK (GSK) United Kingdom $80.799B 9.40
CSL (CSLLY) Australia $67.141B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.547B 14.97
Alnylam Pharmaceuticals (ALNY) United States $58.528B 0.00
Argenex SE (ARGX) Netherlands $43.587B 76.66
Insmed (INSM) United States $28.768B 0.00
BioNTech SE (BNTX) Germany $24.040B 0.00
Royalty Pharma (RPRX) United States $20.983B 8.20
Biogen (BIIB) United States $19.385B 8.26
Incyte (INCY) United States $16.522B 21.05
Genmab (GNMSF) Denmark $16.469B 14.59
Genmab (GMAB) Denmark $15.956B 14.54
Illumina (ILMN) United States $15.364B 24.03
Ascendis Pharma (ASND) Denmark $11.891B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.189B 15.79
Swedish Orphan Biovitrum (BIOVF) Sweden $10.879B 24.06
QIAGEN (QGEN) Netherlands $10.337B 19.82
Exelixis (EXEL) United States $10.074B 18.17
Moderna (MRNA) United States $9.373B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.161B 0.00
Exact Sciences (EXAS) United States $8.978B 0.00
Bio-Techne Corp (TECH) United States $8.564B 31.58
Halozyme Therapeutics (HALO) United States $8.556B 15.05
Guardant Health (GH) United States $8.408B 0.00
Roivant Sciences (ROIV) United Kingdom $8.147B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.749B 41.34
Revolution Medicines (RVMD) United States $7.098B 0.00
Repligen (RGEN) United States $6.881B 75.04
Rhythm Pharmaceuticals (RYTM) United States $6.851B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Anbio Biotechnology (NNNN) Germany $6.481B 0.00
Legend Biotech (LEGN) United States $6.410B 0.00
Abivax SA (ABVX) France $6.124B 0.00
Axsome Therapeutics (AXSM) United States $6.052B 0.00
Avidity Biosciences (RNA) United States $5.993B 0.00
Nuvalent (NUVL) United States $5.522B 0.00
Merus (MRUS) Netherlands $4.980B 0.00
Zealand Pharma (ZLDPF) Denmark $4.887B 4.83
Alkermes (ALKS) Ireland $4.782B 13.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.714B 0.00
TG Therapeutics (TGTX) United States $4.654B 79.27
ACADIA Pharmaceuticals (ACAD) United States $4.385B 40.61
Krystal Biotech (KRYS) United States $4.275B 30.02
Cytokinetics (CYTK) United States $4.227B 0.00
Jyong Biotech (MENS) Taiwan $4.167B 0.00
ADMA Biologics Inc (ADMA) United States $4.119B 29.76
Vaxcyte (PCVX) United States $3.997B 0.00
Ascentage Pharma Group - (AAPG) China $3.948B 0.00
PTC Therapeutics (PTCT) United States $3.919B 6.51
Arcellx (ACLX) United States $3.848B 0.00
Akero Therapeutics (AKRO) United States $3.738B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.711B 0.00
Metsera (MTSR) United States $3.707B 0.00
Zai Lab (ZLAB) China $3.699B 0.00
Protagonist Therapeutics (PTGX) United States $3.674B 84.36
MoonLake Immunotherapeutics (MLTX) Switzerland $3.581B 0.00
Apellis Pharmaceuticals (APLS) United States $3.482B 0.00
Telix Pharmaceuticals (TLX) Australia $3.232B 0.00
Ligand Pharmaceuticals (LGND) United States $3.169B 0.00
Scholar Rock Holding (SRRK) United States $3.139B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.046B 0.00
Viking Therapeutics (VKTX) United States $3.042B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.985B 0.00
Kymera Therapeutics (KYMR) United States $2.946B 0.00
Bavarian Nordic (BVNRY) Denmark $2.913B 14.15
Ultragenyx Pharmaceutical (RARE) United States $2.887B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.618B 0.00
Immunovant (IMVT) United States $2.561B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.482B 837.25
Tarsus Pharmaceuticals (TARS) United States $2.473B 0.00
Alvotech (ALVO) Luxembourg $2.433B 18.34
Liquidia Technologies (LQDA) United States $2.383B 0.00
Amicus Therapeutics (FOLD) United States $2.340B 0.00
Denali Therapeutics (DNLI) United States $2.233B 0.00
ImmunityBio (IBRX) United States $2.212B 0.00
Agios Pharmaceuticals (AGIO) United States $2.191B 0.00
Celcuity (CELC) United States $2.174B 0.00
IDEAYA Biosciences (IDYA) United States $2.152B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.122B 11.90
Disc Medicine (IRON) United States $2.074B 0.00
CG Oncology (CGON) United States $2.045B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.041B 0.00
ANI Pharmaceuticals (ANIP) United States $2.029B 18.19
Adaptive Biotechnologies (ADPT) United States $2.007B 0.00
Belite Bio (BLTE) United States $2.007B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.861B 0.00
Vericel (VCEL) United States $1.835B 303.00
Sarepta Therapeutics (SRPT) United States $1.778B 0.00
Mesoblast (MESO) Australia $1.770B 0.00
Certara (CERT) United States $1.741B 31.88
Apogee Therapeutics (APGE) United States $1.677B 0.00
Cidara Therapeutics (CDTX) United States $1.658B 0.00
Beam Therapeutics (BEAM) United States $1.655B 0.00
Biohaven (BHVN) United States $1.628B 0.00
Twist Bioscience (TWST) United States $1.628B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.623B 0.00
Travere Therapeutics (TVTX) United States $1.560B 0.00
WAVE Life Sciences (WVE) Singapore $1.528B 0.00
Edgewise Therapeutics (EWTX) United States $1.512B 0.00
Viridian Therapeutics (VRDN) United States $1.501B 0.00
Celldex Therapeutics (CLDX) United States $1.466B 0.00
MannKind (MNKD) United States $1.408B 41.73
Syndax Pharmaceuticals (SNDX) United States $1.407B 0.00
Vera Therapeutics (VERA) United States $1.381B 0.00
NovoCure (NVCR) Jersey $1.378B 0.00
Cogent Biosciences (COGT) United States $1.375B 0.00
Janux Therapeutics (JANX) United States $1.365B 0.00
Precigen (PGEN) United States $1.344B 0.00
89BIO (ETNB) United States $1.339B 0.00
AbCellera Biologics (ABCL) Canada $1.249B 0.00
Intellia Therapeutics (NTLA) United States $1.219B 0.00
Novavax (NVAX) United States $1.213B 3.28
CureVac (CVAC) Germany $1.205B 5.59
Pacira BioSciences (PCRX) United States $1.198B 12.70
Dynavax Technologies (DVAX) United States $1.187B 50.60
GRAIL (GRAL) United States $1.182B 0.00
NeoGenomics (NEO) United States $1.134B 0.00
Pharvaris (PHVS) Netherlands $1.132B 0.00
Arcus Biosciences (RCUS) United States $1.127B 0.00
Zymeworks (ZYME) United States $1.113B 0.00
Structure Therapeutics (GPCR) United States $1.112B 0.00
CorMedix Inc (CRMD) United States $1.107B 19.77
LENZ Therapeutics (LENZ) United States $1.102B 0.00
Sionna Therapeutics (SION) United States $1.087B 0.00
Stoke Therapeutics (STOK) United States $1.083B 23.25
MiMedx (MDXG) United States $1.051B 23.67
Mineralys Therapeutics (MLYS) United States $1.026B 0.00
Pharming Group (PHAR) Netherlands $1.021B 0.00
Nuvation Bio (NUVB) United States $1.017B 0.00
Spyre Therapeutics (SYRE) United States $0.996B 0.00
Oric Pharmaceuticals (ORIC) United States $0.994B 0.00
Praxis Precision Medicines (PRAX) United States $0.958B 0.00
Upstream Bio (UPB) United States $0.923B 0.00
Urogen Pharma (URGN) United States $0.900B 0.00
UniQure (QURE) Netherlands $0.896B 0.00
Fortrea Holdings (FTRE) United States $0.894B 15.89
Geron (GERN) United States $0.893B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.883B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.864B 0.00
Anavex Life Sciences (AVXL) United States $0.828B 0.00
Immunome (IMNM) United States $0.828B 0.00
Iovance Biotherapeutics (IOVA) United States $0.807B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.797B 0.00
Niagen Bioscience (NAGE) United States $0.790B 76.15
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
ArriVent BioPharma (AVBP) United States $0.776B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.769B 0.00
Dianthus Therapeutics (DNTH) United States $0.759B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.750B 0.00
Tango Therapeutics (TNGX) United States $0.747B 0.00
Gyre Therapeutics (GYRE) United States $0.745B 154.80
BGM Group (BGM) China $0.730B 0.00
Sana Biotechnology (SANA) United States $0.728B 0.00
Nurix Therapeutics (NRIX) United States $0.714B 0.00
Arbutus Biopharma (ABUS) United States $0.711B 0.00
Oculis Holding AG (OCS) Switzerland $0.704B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Castle Biosciences (CSTL) United States $0.696B 68.60
Vir Biotechnology (VIR) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.686B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.676B 0.00
Tyra Biosciences (TYRA) United States $0.675B 0.00
Zenas BioPharma (ZBIO) United States $0.674B 0.00
Bicara Therapeutics (BCAX) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Rapport Therapeutics (RAPP) United States $0.643B 0.00
Maze Therapeutics (MAZE) United States $0.635B 0.00
Rezolute (RZLT) United States $0.619B 0.00
Immatics (IMTX) Germany $0.619B 0.00
Keros Therapeutics (KROS) United States $0.618B 49.06
Terns Pharmaceuticals (TERN) United States $0.609B 0.00
Palvella Therapeutics (PVLA) United States $0.599B 0.00
Myriad Genetics (MYGN) United States $0.593B 0.00
Inventiva S.A (IVA) France $0.592B 0.00
MeiraGTx Holdings (MGTX) United States $0.587B 0.00
Opthea (OPT) Australia $0.583B 0.00
Verastem (VSTM) United States $0.569B 0.00
AnaptysBio (ANAB) United States $0.569B 0.00
Arvinas (ARVN) United States $0.568B 0.00
Gossamer Bio (GOSS) United States $0.562B 0.00
Septerna (SEPN) United States $0.539B 0.00
ATyr Pharma (ATYR) United States $0.527B 0.00
Cytek Biosciences (CTKB) United States $0.527B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.511B 0.00
MBX Biosciences (MBX) United States $0.507B 0.00
Alumis (ALMS) United States $0.483B 0.00
Compass Therapeutics (CMPX) United States $0.483B 0.00
Tectonic Therapeutic (TECX) United States $0.478B 0.00
Kodiak Sciences (KOD) United States $0.478B 0.00
Eton Pharmaceuticals (ETON) United States $0.464B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
REGENXBIO (RGNX) United States $0.451B 0.00
Northwest Biotherapeutics (NWBO) United States $0.449B 0.00
ITeos Therapeutics (ITOS) United States $0.449B 0.00
Cullinan Therapeutics (CGEM) United States $0.445B 0.00
Erasca (ERAS) United States $0.445B 0.00
Emergent Biosolutions (EBS) United States $0.443B 3.62
Zhengye Biotechnology Holding (ZYBT) China $0.441B 0.00
Prothena (PRTA) Ireland $0.441B 0.00
Prime Medicine (PRME) United States $0.436B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.428B 0.00
Solid Biosciences (SLDB) United States $0.427B 0.00
Replimune (REPL) United States $0.422B 0.00
PureTech Health (PRTC) United States $0.412B 0.00
Inhibrx Biosciences (INBX) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.400B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.399B 0.00
Kamada (KMDA) Israel $0.398B 20.35
XOMA Royalty (XOMA) United States $0.392B 0.00
Aura Biosciences (AURA) United States $0.389B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.389B 0.00
Olema Pharmaceuticals (OLMA) United States $0.375B 0.00
Absci (ABSI) United States $0.357B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.354B 0.00
Fulcrum Therapeutics (FULC) United States $0.351B 0.00
Abeona Therapeutics (ABEO) United States $0.350B 7.42
Astria Therapeutics (ATXS) United States $0.349B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.345B 0.00
I-Mab (IMAB) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.336B 3.64
Candel Therapeutics (CADL) United States $0.318B 0.00
Design Therapeutics (DSGN) United States $0.315B 0.00
Amarin (AMRN) Ireland $0.311B 0.00
Ocugen (OCGN) United States $0.298B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.296B 13.33
DiaMedica Therapeutics (DMAC) United States $0.295B 0.00
ScPharmaceuticals (SCPH) United States $0.293B 0.00
Contineum Therapeutics (CTNM) United States $0.293B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Lifecore Biomedical (LFCR) United States $0.285B 0.00
Crescent Biopharma (CBIO) United States $0.282B 0.00
Tvardi Therapeutics (TVRD) United States $0.281B 0.00
Neumora Therapeutics (NMRA) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
Bright Minds Biosciences (DRUG) United States $0.274B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
Atea Pharmaceuticals (AVIR) United States $0.267B 0.00
DBV Technologies S.A (DBVT) France $0.264B 0.00
Neurogene (NGNE) United States $0.264B 0.00
Cartesian Therapeutics (RNAC) United States $0.261B 0.00
Jade Biosciences (JBIO) United States $0.258B 0.00
Puma Biotechnology (PBYI) United States $0.254B 5.14
Allogene Therapeutics (ALLO) United States $0.251B 0.00
Vor Biopharma (VOR) $0.250B 0.00
Adherex Technologies (FENC) United States $0.247B 0.00
Codexis (CDXS) United States $0.246B 0.00
Humacyte (HUMA) United States $0.245B 0.00
Sagimet Biosciences (SGMT) United States $0.244B 0.00
Alector (ALEC) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.237B 0.00
Prima BioMed (IMMP) Australia $0.236B 0.00
EnGene Holdings (ENGN) Canada $0.236B 0.00
Alpha Teknova (TKNO) United States $0.231B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Annexon (ANNX) United States $0.226B 0.00
Adocia (ADOCY) France $0.216B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.211B 0.00
Monopar Therapeutics (MNPR) United States $0.211B 0.00
Immuneering (IMRX) United States $0.209B 0.00
Entrada Therapeutics (TRDA) United States $0.208B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
SELLAS Life Sciences (SLS) United States $0.202B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.193B 0.00
Rapt Therapeutics (RAPT) United States $0.188B 0.00
Voyager Therapeutics (VYGR) United States $0.186B 0.00
C4 Therapeutics (CCCC) United States $0.185B 0.00
Tenaya Therapeutics (TNYA) United States $0.184B 0.00
Instil Bio (TIL) United States $0.182B 0.00
Aardvark Therapeutics (AARD) United States $0.180B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.180B 0.00
Tevogen Bio Holdings (TVGN) United States $0.179B 0.00
Cognition Therapeutics (CGTX) United States $0.179B 0.00
BioAge Labs (BIOA) United States $0.177B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Elicio Therapeutics (ELTX) United States $0.172B 0.00
Ventyx Biosciences (VTYX) United States $0.171B 0.00
Citius Oncology (CTOR) United States $0.170B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.169B 0.00
Nuvectis Pharma (NVCT) United States $0.167B 0.00
Seres Therapeutics (MCRB) United States $0.166B 0.00
Kyverna Therapeutics (KYTX) United States $0.160B 0.00
Sangamo Therapeutics (SGMO) United States $0.157B 0.00
Black Diamond Therapeutics (BDTX) United States $0.157B 11.96
Greenwich LifeSciences (GLSI) United States $0.156B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.156B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.151B 0.00
Climb Bio (CLYM) United States $0.151B 0.00
Nkarta (NKTX) United States $0.151B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
MaxCyte (MXCT) United States $0.148B 0.00
Cellectis S.A (CLLS) France $0.143B 0.00
Cardiff Oncology (CRDF) United States $0.140B 0.00
Forte Biosciences (FBRX) United States $0.137B 0.00
Anika Therapeutics (ANIK) United States $0.135B 0.00
TuHURA Biosciences (HURA) United States $0.135B 0.00
Coherus Oncology (CHRS) United States $0.135B 0.00
BioHarvest Sciences (BHST) Canada $0.134B 0.00
Alpha Cognition (ACOG) Canada $0.134B 0.00
Zura Bio (ZURA) United States $0.133B 0.00
Cabaletta Bio (CABA) United States $0.133B 0.00
Inovio Pharmaceuticals (INO) United States $0.126B 0.00
Compugen (CGEN) Israel $0.126B 0.00
Genelux (GNLX) United States $0.126B 0.00
Scilex Holding (SCLX) United States $0.124B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.122B 0.00
Fate Therapeutics (FATE) United States $0.120B 0.00
BioStem Technologies (BSEM) $0.119B 6.23
Invivyd (IVVD) United States $0.117B 0.00
Spero Therapeutics (SPRO) United States $0.116B 0.00
Biomea Fusion (BMEA) United States $0.116B 0.00
Seer (SEER) United States $0.116B 0.00
Connect Biopharma Holdings (CNTB) United States $0.115B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Skye Bioscience (SKYE) United States $0.108B 0.00
InflaRx (IFRX) Germany $0.107B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.106B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
IO Biotech (IOBT) Denmark $0.104B 0.00
23andMe Holding (MEHCQ) United States $0.104B 0.00
Equillium (EQ) United States $0.104B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.103B 0.00
VistaGen Therapeutics (VTGN) United States $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Pliant Therapeutics (PLRX) United States $0.101B 0.00
Adagene (ADAG) China $0.100B 0.00
Alto Neuroscience (ANRO) United States $0.100B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
Elutia (ELUT) United States $0.097B 0.00
XBiotech (XBIT) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Celularity (CELU) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.091B 0.00
CervoMed (CRVO) United States $0.089B 0.00
OKYO Pharma (OKYO) $0.088B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Nautilus Biotechnology (NAUT) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Immunic (IMUX) United States $0.081B 0.00
KALA BIO (KALA) United States $0.079B 0.00
Artiva Biotherapeutics (ARTV) United States $0.077B 0.00
Fortress Biotech (FBIO) United States $0.077B 0.00
Kalaris Therapeutics (KLRS) United States $0.076B 0.00
Opus Genetics (IRD) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.073B 0.00
Repare Therapeutics (RPTX) Canada $0.072B 0.00
Applied Therapeutics (APLT) United States $0.071B 0.00
TELA Bio (TELA) United States $0.071B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.065B 0.00
Aligos Therapeutics (ALGS) United States $0.065B 0.00
BioXcel Therapeutics (BTAI) United States $0.065B 0.00
Adverum Biotechnologies (ADVM) United States $0.065B 0.00
MiNK Therapeutics (INKT) United States $0.064B 0.00
Quantum Biopharma (QNTM) Canada $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
ALX Oncology Holdings (ALXO) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
INmune Bio (INMB) United States $0.054B 0.00
ImageneBio (IMA) United States $0.054B 0.00
Clene (CLNN) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.046B 0.00
Jasper Therapeutics (JSPR) United States $0.046B 0.00
Annovis Bio (ANVS) United States $0.045B 0.00
Lantern Pharma (LTRN) United States $0.044B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
Radiopharm Theranostics - (RADX) Australia $0.043B 0.00
X4 Pharmaceuticals (XFOR) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.041B 0.00
Renovaro (RENB) United States $0.041B 0.00
Generation Bio (GBIO) United States $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Senti Biosciences (SNTI) United States $0.038B 0.00
PepGen (PEPG) United States $0.038B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Exicure (XCUR) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Tharimmune (THAR) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
BioAtla (BCAB) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Passage Bio (PASG) United States $0.023B 0.00
Allarity Therapeutics (ALLR) United States $0.023B 0.00
Rallybio (RLYB) United States $0.022B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.020B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.020B 0.00
Synaptogenix (TAOX) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.015B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Soligenix (SNGX) United States $0.013B 0.00
Longeveron (LGVN) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Femasys (FEMY) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Apollomics (APLM) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00